Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial

L.-M. Huang, T. Puthanakit, C. Cheng-Hsun, T. Ren-Bin, T. Schwarz, A. Pellegrino, S. Esposito, L. Frenette, S. McNeil, P. Durando, P. Rheault, C. Giaquinto, M. Horn, K.U. Petry, K. Peters, T. Azhar, P. Hillemanns, S. De Simoni, D. Friel, S. PemmarajuM. Hezareh, F. Thomas, D. Descamps, N. Folschweiller, F. Struyf

Research output: Contribution to journalArticle

Cite this

Huang, L-M., Puthanakit, T., Cheng-Hsun, C., Ren-Bin, T., Schwarz, T., Pellegrino, A., Esposito, S., Frenette, L., McNeil, S., Durando, P., Rheault, P., Giaquinto, C., Horn, M., Petry, K. U., Peters, K., Azhar, T., Hillemanns, P., De Simoni, S., Friel, D., ... Struyf, F. (2017). Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial. The Journal of infectious diseases, 215(11), 1711-1719. https://doi.org/10.1093/infdis/jix154